Early-stage hepatocellular carcinoma screening in patients with chronic hepatitis B in China: a cost-effectiveness analysis

Conclusion: GAAD+US was the most cost-effective strategy for early HCC diagnosis among CHB patients which could be considered as the liver cancer screening scheme for the high-risk population in China.PMID:38415341 | DOI:10.57264/cer-2023-0146

Source: Journal of Comparative Effectiveness Research - February 28, 2024 Category: General Medicine Authors: Yuemin Nan Osvaldo Ulises Garay Xianzhong Lu Yue Zhang Li Xie Zhongyi Niu Wen Chen Source Type: research